ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 628,57
-0,56%
Dow Jones
39 150,33
0,04%
DAX
18 163,52
-0,41%
Brent Oil
84,39
0,00%
Bitcoin
64 277,48
0,30%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Bausch Health Companies Inc (BHC)

  7. Bausch Health Companies Inc (BHC) Actualités

BHC

Bausch Health Companies (BHC)

Bausch Health Companies Inc
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:BHC
DateHeureSourceTitreSymboleSociété
06/06/202423h18Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NYSE:BHCBausch Health Companies Inc
21/05/202422h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BHCBausch Health Companies Inc
21/05/202422h01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:BHCBausch Health Companies Inc
15/05/202414h07Edgar (US Regulatory)Form 8-K - Current reportNYSE:BHCBausch Health Companies Inc
04/03/202416h36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:BHCBausch Health Companies Inc
22/02/202423h04Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:BHCBausch Health Companies Inc
13/02/202422h30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:BHCBausch Health Companies Inc
08/02/202403h00Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NYSE:BHCBausch Health Companies Inc
13/11/202322h50Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:BHCBausch Health Companies Inc
02/11/202321h58Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:BHCBausch Health Companies Inc
21/10/202300h05Dow Jones NewsBausch Health Gets FDA Approval for Acne Treatment CabtreoNYSE:BHCBausch Health Companies Inc
26/09/202311h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Bausch Health Companies Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 25, 2023 - (NYSE: BHC)NYSE:BHCBausch Health Companies Inc
03/08/202323h25Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:BHCBausch Health Companies Inc
26/07/202311h45PR Newswire (US)INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Bausch Health Companies Inc. of an Investigation and Potential Class Action Lawsuit - (NYSE: BHC)NYSE:BHCBausch Health Companies Inc
21/07/202311h45PR Newswire (US)BHC FRAUD ALERT: Jakubowitz Law is Investigating Bausch Health Companies Inc. in Connection with Potential Violations of Federal Securities LawsNYSE:BHCBausch Health Companies Inc
19/07/202322h02Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:BHCBausch Health Companies Inc
06/06/202317h30Dow Jones NewsBausch Health Shares Drop After Norwich Sues FDA for Final OK for Rival DrugNYSE:BHCBausch Health Companies Inc
31/05/202314h00PR Newswire (US)OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum DiseaseNYSE:BHCBausch Health Companies Inc
19/05/202322h28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:BHCBausch Health Companies Inc
17/05/202314h17Edgar (US Regulatory)Current Report Filing (8-k)NYSE:BHCBausch Health Companies Inc
03/05/202312h58PR Newswire (Canada)RYALTRIS®, a new combination prescription nasal spray for moderate to severe seasonal allergic rhinitis (SAR), now available across CanadaNYSE:BHCBausch Health Companies Inc
03/05/202312h58PR Newswire (Canada)RYALTRIS(MD), une nouvelle association sous ordonnance en pulvérisateur nasal pour la rhinite allergique saisonnière (RAS) d'intensité modérée à grave, est maintenant disponible partout au CanadaNYSE:BHCBausch Health Companies Inc
06/04/202322h50Edgar (US Regulatory)Annual Report to Security Holders (ars)NYSE:BHCBausch Health Companies Inc
06/04/202322h48Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:BHCBausch Health Companies Inc
06/04/202322h47Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:BHCBausch Health Companies Inc
06/03/202319h33Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NYSE:BHCBausch Health Companies Inc
23/02/202323h31Edgar (US Regulatory)Annual Report (10-k)NYSE:BHCBausch Health Companies Inc
14/02/202316h41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:BHCBausch Health Companies Inc
22/12/202212h59PR Newswire (Canada)First tazarotene lotion treatment for acne vulgaris, ARAZLO™ (tazarotene lotion, 0.045%), now available to patients through Quebec, Ontario, Alberta, Saskatchewan and federal NIHB public drug plansNYSE:BHCBausch Health Companies Inc
22/12/202212h59PR Newswire (Canada)ARAZLOMC (lotion de tazarotène, 0,045 %), la première lotion à base de tazarotène indiquée pour le traitement de l'acné vulgaire, est maintenant offerte aux patients du Québec, de l'Ontario, de l'Alberta et de la Saskatchewan dans le cadre des régiNYSE:BHCBausch Health Companies Inc
 Showing the most relevant articles for your search:NYSE:BHC

Dernières Valeurs Consultées

BIT
UC0JN5
Unicredit Bank
TSX
ZINN
BMO MSCI Innovation Inde...
USOTC
MRLLF
Minera IRL (QB)
EU
XS1423753463
NIBC Bank 0.625% 01jun2026
EU
HSPCP
EN HELIOS SPACE
EU
5236T
5236T
TSXV
WLK.P
LSE
EUE
Ishr E Stx 50-i
TG
A161RX
Bavarian State Soil Loan...
DGFX
CMQUSDT
COMMUNIQUE
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés